uniQure Pharma (QURE): Nilai pasar

The market price visualization for uniQure N.V. (QURE) is presented below; the company has optimized drug production by delegating final testing to external contractors to minimize risks. This biotech leader is implementing advanced treatments for orphan diseases while actively investing in scientific research. The business economics rely on partnership royalties, medical trial results, and the efficiency of its own plants, with a market capitalization of 1.58.

uniqure.com - Nilai pasar QURE (periode 04.07.2022 - 22.10.2026)

uniQure Pharma - rincian analitis lan metrik utama (QURE)

Indikator keuangan lan pasar perusahaan uniQure N.V. (QURE):

Kutipan saham uniQure|QURE - Prakiraan konsensus analis|Nilai pasar uniQure Pharma

Analisis fundamental perusahaan:uniQure (QURE)

Produk asli uniQure Pharma

The current market valuation of uniQure N.V. (QURE) reflects market optimism regarding royalties from hemophilia B therapy and the potential of new developments targeting Alzheimer's and Huntington's diseases. This indicator is calculated as the product of the total number of shares and their current price, capturing the objective scale of the business and signaling correction risks in the event of overvalued quotes or negative financial reporting.

Pesaing uniQure N.V.

Tempus - Biji pasar|Kapitalisasi pasar Qiagen NV QGEN|IONS - Nilai pasar|Nilai pasar RGEN (Repligen Inc.)|RNA: Kapitalisasi pasar|Nilai pasar crisprtx.com (CRSP)|WGS (GeneDx) - Kapitalisasi pasar|Kapitalisasi pasar RARE (Ultragenyx Pharmaceutical Inc.)|Nilai pasar Beam Therapeutics Corp (BEAM)|Sarepta Corp - Kapitalisasi pasar|Kapitalisasi pasar TWST (Twist Bioscience)|Kapitalisasi pasar 10xgenomics.com TXG|NTLA: Biji pasar|STOK - Kapitalisasi pasar|BioLife Corp (BLFS) - Nilai pasar|Kapitalisasi pasar WVE|MAZE (Maze Therapeutics Inc) - Kapitalisasi pasar|sionnatx.com (SION) - Kapitalisasi pasar|Nilai pasar Prime Medicine (PRME)|Taysha Gene Therapies Inc (TSHA) - Kapitalisasi pasar|MeiraGTx PLC - Biji pasar|Kapitalisasi pasar REGENXBIO Corp RGNX|SLDB - Nilai pasar|Nilai pasar OCGN (ocugen.com)|PACB: Kapitalisasi pasar|Nilai pasar Benitec Biopharma Inc (BNTC)|Biji pasar DSGN|RCKT: Nilai pasar|Nilai pasar 4D Molecular Therapeutics (FDMT)|lexeotx.com - Kapitalisasi pasar|Korro Bio - Biji pasar|Kapitalisasi pasar Editas Medicine Inc (EDIT)|SLN: Biji pasar|PRQR: Nilai pasar|CDXS (codexis.com) - Biji pasar|SGMO - Kapitalisasi pasar|Nilai pasar Nautilus Biotechnology, Inc.|MGX - Kapitalisasi pasar|Biji pasar DTIL (Precision BioSciences)|Kapitalisasi pasar generationbio.com (GBIO)|Nilai pasar Boundless Bio, Inc. BOLD|Nilai pasar XCUR|Celsion Corporation - Kapitalisasi pasar|Nilai pasar Phio Pharmaceuticals|MBIO: Kapitalisasi pasar|Kapitalisasi pasar RNAZ|Nilai pasar Bionano Genomics Inc.|Kapitalisasi pasar APDN (adnas.com)|Kapitalisasi pasar BLUE|Kapitalisasi pasar immunoprecise.com (IPA)|Omega - Biji pasar|Kapitalisasi pasar Singular Genomics Corp OMIC|RGLS - Nilai pasar|SYRS (syros.com) - Kapitalisasi pasar|TBIO: Kapitalisasi pasar|TCON - Kapitalisasi pasar|Nilai pasar Unity Bio